SEATTLE, WA , Nov 10, 2009 – The National Institutes of Health (NIH) has awarded the Institute for Systems Biology, a non-profit biomolecular research institute based in Seattle, WA, nearly $8 million to help identify new drug targets and therapies for many of the most lethal cancers, in one of the most significant endeavors since the Human Genome Project: The Cancer Genome Atlas (TCGA).
Dr. Aderem discusses the work of his lab, how systems biology approaches are enabling a deep understanding the immune system's response to infections, and how these insights will lead to better strategies for combating pandemic infectious diseases.
New York, – June 6, 2008 – Three of the United States' most prominent biomedical science leaders have been tapped by the government of Luxembourg for an unprecedented international collaboration to establish a bioscience center of excellence in the heart of the European Union.
On May 4 local researchers and public health officials, several of whom are national leaders in infectious disease research and policy, gathered to discuss the current swine flu outbreak and take questions from members of the community. ISB Senior Research Scientist Alan Dierks participated on the panel.
"I think the thing that is most unique about P4 Medicine is that it will represent a network of networks - genetic networks, molecular networks, cellular networks, tissue networks, individual networks, population networks, social networks."
President of Institute for Systems Biology
Director of Communications